170.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank Ana - GuruFocus
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript - Insider Monkey
Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank | D - GuruFocus
Is Quest Diagnostics Incorporated a good long term investmentConsistently exceptional gains - Autocar Professional
Quest Diagnostics Inc (DGX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo.co
DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth - TradingView
Quest Diagnostics Lifts Outlook As Testing Demand Grows - Finimize
Quest Diagnostics Surges to 241st in Daily Rankings with $476 Million Turnover - AInvest
What analysts say about Quest Diagnostics Incorporated stockExceptional earning trajectories - jammulinksnews.com
What drives Quest Diagnostics Incorporated stock priceSuperior trading gains - jammulinksnews.com
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics Well Positioned to Benefit From Strong Medical Utilization - Morningstar
Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks - Yahoo Finance
Quest Diagnostics Reports Strong Q2 Earnings, Exceeds ExpectationsNews and Statistics - IndexBox
Quest Diagnostics rises on upbeat results, guidance raise (DGX:NYSE) - Seeking Alpha
Quest Diagnostics raises annual forecasts on strong diagnostic testing demand - whbl.com
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises - The Globe and Mail
Quest Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Quest Diagnostics: Q2 Earnings Snapshot - NewsTimes
Quest Diagnostics' Q2 2025 Earnings: A Strategic Analysis of Its Position in the Evolving Diagnostic Services Landscape - AInvest
Quest Diagnostics Inc (DGX) Q2 2025 Earnings: EPS of $2.47 Beats Estimates, Revenue Hits $2.76 Billion - GuruFocus
Quest Diagnostics Q2 2025 slides: revenue growth accelerates, guidance raised - Investing.com Canada
Quest Diagnostics (DGX) Boosts FY25 Revenue Outlook Amid Growth and Efficiency Gains | DGX Stock News - GuruFocus
Quest Diagnostics (DGX) Exceeds Revenue Expectations in Strong Q - GuruFocus
Quest (NYSE:DGX) Surprises With Q2 Sales - TradingView
Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $2.57 - MarketScreener
Quest Diagnostics Reports Second Quarter 2025 Financial Results - TradingView
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PR Newswire
Quest Diagnostics Earnings Preview: EPS Estimate $2.57, Neutral Consensus Rating, and 12.46% Upside Potential. - AInvest
Quest Diagnostics Earnings Preview - Nasdaq
Should You Buy Quest Diagnostics Ahead Of Earnings? - Barchart.com
Should You Buy Quest Diagnostics Ahead of Earnings? - The Globe and Mail
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance? - TradingView
Quest (DGX) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Quest Diagnostics Incorporated Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com
Quest Diagnostics (DGX) Maintains Neutral Rating Amid Slight PT Adjustment | DGX Stock News - GuruFocus
Quest Diagnostics: UBS Keeps Neutral Rating, Lowers PT to $175 from $176 - AInvest
Quest Diagnostics (DGX) Faces Slight Price Target Adjustment by UBS | DGX Stock News - GuruFocus
11th Circ. Says Ex-Quest Diagnostics Worker's FCA Suit Fails - Law360
Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Quest Lab Worker Fails to Revive Billing Fraud Suit on Appeal - Bloomberg Law News
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test - MedTech Dive
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Quest Diagnostics launches test for Oropouche virus amid spread in Americas - Investing.com Canada
Quest Diagnostics (DGX) Launches Oropouche Virus Test | DGX Stoc - GuruFocus
Quest Diagnostics Introduces Testing for Oropouche Virus - MarketScreener
First-Ever Commercial Test for Dangerous Oropouche Virus Launches as Disease Spreads in Americas - Stock Titan
Quest Diagnostics: Buy Into Future Patient Demand, Undervalued Price Today (DGX) - Seeking Alpha
Quest Diagnostics launches test for Oropouche virus detection in United States; company's California lab will perform PCR testing for emerging disease starting late July 2025 - Industry Intelligence Inc.
Despite Slump, Options Traders May Be Seeing Something With Quest Diagnostics (DGX) - Barchart.com
Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center - Yahoo Finance
Quest Diagnostics Stock Drops 2.51% Amid Analyst Upgrade - AInvest
Quest Diagnostics Surges to 417th in Trading Volume with 2.25 Billion Shares Traded - AInvest
Quest Diagnostics (DGX) Launches FDA-Approved Alzheimer's Test - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):